Expertise in
12
conditions

David P. D'cruz

Guys And St Thomas' Hospitals, 
London, ENG, GB 
Expertise in
12
conditions
Guys And St Thomas' Hospitals, 
London, ENG, GB 

Overview

David D'cruz practices practicing medicine in London, United Kingdom.

Mr. D'cruz is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Relapsing Polychondritis, Systemic Lupus Erythematosus (SLE), Retroperitoneal Fibrosis, Lupus Nephritis, and Angioplasty.

He is actively involved in clinical research, co-authoring 171 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Guys And St Thomas' Hospitals, London, ENG, United Kingdom
Other Locations
St Thomas' Hospital, Westminster Bridge Road, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: April 23, 2024
Intervention Type: Drug
Study Drug: LY3471851
Study Phase: Phase 2
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 29, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
Phase 3 Open Label Randomised Multicentre Controlled Trial of Rituxmab and Mycophenolate Mofetil Without Oral Steroids for the Treatment of Lupus Nephritis
Phase 3 Open Label Randomised Multicentre Controlled Trial of Rituxmab and Mycophenolate Mofetil Without Oral Steroids for the Treatment of Lupus Nephritis
Enrollment Status: Terminated
Publish Date: February 01, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

171 Total Publications

Bringing back 'significance' to MGUS.
Bringing back 'significance' to MGUS.
Journal: Rheumatology (Oxford, England)
Published: January 28, 2026

Frequently Asked Questions about David P. D'cruz

Is David P. D'cruz a top-rated expert for Relapsing Polychondritis?

MediFind is an objective health platform that identifies experts based on real-world data. David P. D'cruz is classified as an Elite expert for Relapsing Polychondritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does David P. D'cruz participate in research or clinical trials?

Yes. David P. D'cruz has published 171 articles and abstracts on conditions like Relapsing Polychondritis. You can view a list of David P. D'cruz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. D'cruz's expertise for a condition
ConditionClose
View All 37 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile